LGALS1 and Hepatic fibrosis: Our results not only demonstrated the cooperative effect of Gal-1 and glycosylation changes in HSC activation but also implied that targeting glycosylation-dependent Gal-1/NRP-1 interactions might be effective in liver fibrosis therapy.